Drug profile · INN
vedolizumab
ENTYVIO
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
vedolizumab (ENTYVIO) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN vedolizumab
Brand ENTYVIO
Route INJECTION
Formulation INJECTABLE
Originator Takeda Pharmaceuticals International AG
Related patents
Search patents →Frequently asked questions
What is vedolizumab?
vedolizumab (ENTYVIO) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for vedolizumab?
ENTYVIO is a marketed brand name for vedolizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vedolizumab?
vedolizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.